Medicines regulator Swissmedic has approved the booster of the single-dose vaccine from Johnson & Johnson.
“The second dose of the vaccine can be administered, at the earliest, two months after the first dose,” wrote Swissmedic in a statement on Monday.
Swissmedic has also approved the use of Janssen as a booster for mRNA vaccines. It can be administered six months after the second dose of an mRNA vaccine.
“This is the first time in Switzerland that an applicant has submitted clinical data on a mixed vaccination,” wrote Swissmedic.
The Janssen viral vector model vaccine was first approved in March. In September the Swiss government signed a contract to purchase 150,000 doses. The vaccine is based on a human cold virus that contains the blueprint for the “spike” protein of the novel coronavirus.
The other two vaccines approved in Switzerland – Moderna and by Pfizer/BioNTech – use mRNA technology, a process that injects a fragment of the coronavirus blueprint into human cells to prompt the body to produce a defensive response.
Moderna boost
The Swiss government has exercised its option to purchase an additional seven million doses of Moderna’s booster vaccine for delivery in the second half of 2022, the company said on Monday. These vaccine, approved as booster in November, would be in addition to the first seven million doses ordered by the government for 2022. In total, this brings Switzerland’s order to 27.5 million doses of the mRNA vaccine.
Most Read Swiss Abroad
More
Swiss government open to reversing ban on new nuclear plants
Bodycams: essential for good law enforcement, or a privacy risk?
Did you ever come across bodycams in your place of residence and if so, how do you think the use of bodycams alter the relationship between the public and (transport) police?
What can be done to protect biodiversity in your country?
Swiss voters are set to decide on a people’s initiative calling for better protection of ecosystems in the country. Have your say on the September 22 vote.
Swiss government pensions come under pressure in parliament
This content was published on
A parliamentary committee is favour of scrapping the generous pensions enjoyed by former government ministers and federal judges.
This content was published on
Appointed in April as the EU's incoming ambassador, Slovak man Miroslav Lajčák will ultimately not take up the post in Bern this year.
SNB boss: as a leading financial hub, Swiss must accept risks
This content was published on
The outgoing head of the Swiss National Bank, Thomas Jordan, says the country should aim to preserve its leading financial position.
Top Swiss court rules against prostitution exclusion zone
This content was published on
The Federal Court ruled that a Swiss town went too far in banning prostitution within a 100-metre radius of certain sensitive locations.
First UN fact-finding report on Sudan released in Geneva
This content was published on
Numerous acts amounting to crimes against humanity and war crimes have been committed in Sudan, according to UN investigators.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss regulator approves Pfizer/BioNTech booster for 16 and up
This content was published on
Swissmedic has approved the extension of Covid-19 boosters to all people 16 years of age and over for the Pfizer/BioNTech vaccine.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.